SCHEMBL6274764

SCHEMBL6274764

CC1=CC2=CC3=NC(=CC4=NC(=CC5=NC(=C(C)C1=N2)C(C)=C5C)C=C4[Fe])C=C3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3522154 0.71 — —
SCHEMBL13953187 0.59 — —
SCHEMBL22555574 0.58 — —
SCHEMBL466965 0.57 — —
SCHEMBL2847937 0.57 — —
SCHEMBL9744433 0.56 — —
SCHEMBL4797006 0.55 PABPC1 (0.33) —
SCHEMBL3811064 0.55 — —
SCHEMBL21633743 0.55 — —
SCHEMBL22389533 0.54 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1512399-A1 PORPHYRIN OXYGEN INFUSION PREPARATION FOR INCREASING OXYGEN CONCENTRATION IN TUMOR TISSUE Nipro Corporation (JP) 2005-03-09 — — EP disclosed
Send feedback